Carbapenemase-Producing Enterobacteriaceae in Intensive Care Unit: How to Manage the Risk ?

Authors

  • J.-R. Zahar Unité de contrôle et de prévention du risque infectieux, département de microbiologie clinique, groupe hospitalier Paris-Seine-Saint-Denis, AP–HP, Bobigny France
  • J.-Y. Mootien Service de réanimation médicale, unité de conseil en antibiothérapie, groupe hospitalier région Mulhouse et Sud-Alsace
  • B. Pilmis Équipe mobile d’infectiologie, laboratoire de microbiologie, groupe hospitalier Paris-Saint-Joseph

DOI:

https://doi.org/10.3166/rea-2018-0057

Keywords:

Intubation, Hypotension, Hypnotic agents, Sedation, Vasopressors

Abstract

The global widespread of carbapenemase-producing enterobacteriaceae, particularly in the Mediterranean area is a challenging situation that needs to keep us alert. Three principal mechanism of resistance, displaying variable expression, are described here in this article. Identifying patient at risk, improving the quality of our microbiological diagnosis and containing the widespread of the resistance in healthcare facilities are essential to help keeping this problem under control. Improvement of hand hygiene compliance, respect of hygiene precaution procedures, and optimizing antibiotic consumption are more than necessary.

Published

2018-07-15

How to Cite

Zahar, J.-R., Mootien, J.-Y., & Pilmis, B. (2018). Carbapenemase-Producing Enterobacteriaceae in Intensive Care Unit: How to Manage the Risk ?. Médecine Intensive Réanimation, 27(4), 367–371. https://doi.org/10.3166/rea-2018-0057